Friedreich ataxia

Active Research Protocols

  1. 05-N-0245 – A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients with Friedreich's Ataxia
  2. 09-N-0197 – Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients with Primary Progressive Multiple Sclerosis
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014